Q&A: Charles Zorumski, MD: Depression and Substance Use Disorders
Dr. Zorumski is the Samuel B. Guze Professor and Head of the Department of Psychiatry, and Professor of Neuroscience at Washington University School …
Dr. Zorumski is the Samuel B. Guze Professor and Head of the Department of Psychiatry, and Professor of Neuroscience at Washington University School …
Live today, neuroscienceCME Live and On Demand Bipolar Disorder – A Focus on Depression. [More…]…
A study published today in Lancet investigated whether experienced discrimination in depression is related to clinical history, provision of health care, and disclosure of diagnosis and whether anticipated discrimination is associated with disclosure and previous experiences of discrimination.
A cross-sectional …
Research published in Lancet this week, assessed the nature and severity of experienced and anticipated discrimination reported by adults with major depressive disorder worldwide.
In a cross-sectional survey, people with a diagnosis of major depressive disorder were interviewed in 39 …
How close are we to implementing the idea of personalized medicine in psychiatry? Next year the International Congress on Neuropsychopharmacology (CINP) is holding a thematic meeting in April 2013 entitled “Pharmacogenomics and Personalized Medicine in Psychiatry.” An ‘All …
A study published in Comprehensive Psychiatry evaluated the impact of negative symptoms and depression on psychological well-being in individuals with schizophrenia.
A number of previous studies have demonstrated that negative symptoms are linked to lower rates of recovery in individuals …